1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Subcutaneous Markets for Biotherapeutics

Subcutaneous Markets for Biotherapeutics

  • December 2015
  • -
  • Greystone Research Associates


In recent years, the number of biological drugs in development and reaching the marketplace has increased significantly. The clinical application of these drugs is sometimes limited by a lack of desirable attributes relative to market needs and opportunities. To realize the full therapeutic and commercial potential of biologicals, drug developers and technologists are applying a number of innovative solutions which are aimed at addressing the limitations of biological drugs one by one. Initiatives include formulation techniques, drug processing strategies and subcutaneous injection device design and customization. These technologies are addressing a range of issues that include drug stability, physical properties, drug release profiles and dosing volumes, factors that can directly affect the ability of drugs to be administered subcutaneously.

What You Will Learn

- What are the major limitations holding back the trend toward self administration of biotherapeutic drugs?
- What are the technology initiatives and solutions being applied to biotherapeutic drugs and drug candidates to enable their delivery via subcutaneous injection?
- Who are the important technology suppliers, their capabilities, and their drug development partners?
- What is the market for subcutaneous biotherapeutics today? What will it be in 2022?
- How important are drug developer-technology partner relationships to commercial success?
- What are the essential design factors, technologies and market development issues for increasing the commercial potential of biotherapeutic drugs?
- How are biotherapeutic technology solutions aligned with various drug classes and therapeutic markets?
- What are the significant economic, technology, and regulatory factors affecting subcutaneous biotherapeutics?

Table Of Contents

Subcutaneous Markets for Biotherapeutics
Executive Summary

Therapeutic Biologicals - Challenges and Risks
The Biological Therapeutics Market Space
Drug Properties - Limits and Constraints
Half?Life and Therapeutic Protocols
Dug Viscosities
Drug Volumes
Market Sector Demand Drivers
Diseases and Indications
Patient Population Demographics
Access and Reimbursement
Developing Economies
Biotherapeutics - The Competitive Landscape

Biotherapeutics Administration - Product Strategies
Processing Strategies
Dual Chamber Devices
Custom Recon Systems
Third Party Recon Solutions
Formulation Strategies
Extended/Sustained Release
Biodegradable Polymers
Delivery Device Strategies
High Visc Autoinjectors
Wearable SC Infusion Devices
Large Volume Injectors
Other Device Classes

Subcutaneous Biotherapeutics - The Current Market
Growth Factors
Immune Modulators
Other Protein Therapy Classes

Biotherapeutic Market Segments - Analysis, Market Data and Forecasts
Autoimmune Diseases
Blood Factors and Hematopoietics
Hormone Replacement
Infectious Diseases
Metabolic Diseases
Reproductive Health
Respiratory Conditions
Orphan Diseases

Biotherapeutics - Commercialization and Market Factors
Regulatory Factors and Issues
Managed Care and Healthcare Economics

Company Profiles

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
T-Cell Immunotherapy Market (2nd Edition), 2017-2030

T-Cell Immunotherapy Market (2nd Edition), 2017-2030

  • $ 2449
  • Industry report
  • January 2017
  • by Roots Analysis Private Ltd.

INTRODUCTION The concept of immunotherapies dates back to the 18th century; however, since inception, the field has evolved tremendously and is currently cited as one of the most rapidly growing segments ...

Global Next-Generation Biologics Market 2016-2020

Global Next-Generation Biologics Market 2016-2020

  • $ 2500
  • Industry report
  • November 2016
  • by Infiniti Research Limited

About Next-generation Biologics According to the section 351 of the Public Health Service Act of the US FDA, a biological product is defined as a “virus, therapeutic serum, antitoxin, vaccine, toxin, ...

Viral Vectors and Plasmid DNA Manufacturing Market, 2016-2026

Viral Vectors and Plasmid DNA Manufacturing Market, 2016-2026

  • $ 2349
  • Industry report
  • October 2016
  • by Roots Analysis Private Ltd.

INTRODUCTION Gene therapy has emerged as a promising treatment option for various diseases (primarily the ones that currently have no cure) including cancers, inherited disorders and some viral infections. ...

Download Unlimited Documents from Trusted Public Sources

Biological Therapy Industry in Canada

  • December 2016
    7 pages
  • Biological Ther...  


  • Canada  

View report >

Cytokine Industry in the US

  • November 2016
    10 pages
  • Cytokine  


  • United States  


View report >

Biological Therapy Industry in the UK - Forecast

  • April 2016
    18 pages
  • Tissue Engineer...  

    Cell Therapy  

    Gene Therapy  

  • United Kingdom  


View report >

Related Market Segments :



Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.